Načítá se...
Anticoagulation Resumption After Intracerebral Hemorrhage
PURPOSE OF REVIEW: Decision-making on resuming oral anticoagulant (OAC) after intracerebral hemorrhage (ICH) evokes significant debate among clinicians. Such patients have been excluded from randomized clinical trials. This review article provides a comprehensive summary of the evidence on anticoagu...
Uloženo v:
| Vydáno v: | Curr Atheroscler Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5960649/ https://ncbi.nlm.nih.gov/pubmed/29781063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-018-0733-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|